![](https://canaan.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZW89IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--09d3b489226af86b35e2aeeb69f07122ecddaf7b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9VWTI5dFltbHVaVjl2Y0hScGIyNXpld2M2QzNKbGMybDZaVWtpQ1RVeE1sNEdPZ1pGVkRvSmRISnBiVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--227fdc48d0cc0381319025b1f375233c6a320fb3/praecispharmaceuticals.png)
Praecis Pharmaceuticals
Praecis Pharmaceuticals focuses on peptide-based therapeutics that have the potential to address unmet medical needs or improve existing therapies.
Investment
Series A
Praecis Pharmaceuticals focuses on peptide-based therapeutics that have the potential to address unmet medical needs or improve existing therapies.
Series A